Revenue: As of FY2025 Q3, the actual value is USD 247.87 K.EPS: As of FY2025 Q3, the actual value is USD 0.47.EBIT: As of FY2025 Q3, the actual value is USD -1.107 M.<h3>Segment Revenue</h3><ul><li>Product Sales: $247,868 for the three months ended September 30, 2025, compared to $607,161 for the same period in 2024, representing a decrease of 59.2%.</li><li>Product Sales: $802,396 for the nine months ended September 30, 2025, compared to $3,024,112 for the same period in 2024, representing a decrease of 73.5%.</li></ul><h3>Operational Metrics</h3><ul><li>Gross Profit: $188,115 for the three months ended September 30, 2025, compared to $452,874 for the same period in 2024, representing a decrease of 58.5%.</li><li>Gross Profit: $538,609 for the nine months ended September 30, 2025, compared to $2,226,547 for the same period in 2024, representing a decrease of 75.8%.</li><li>Operating Expenses: $1,430,118 for the three months ended September 30, 2025, compared to $954,951 for the same period in 2024, representing an increase of 49.8%.</li><li>Operating Expenses: $6,789,955 for the nine months ended September 30, 2025, compared to $4,223,716 for the same period in 2024, representing an increase of 60.8%.</li><li>Net Loss: $3,067,067 for the three months ended September 30, 2025, compared to $726,585 for the same period in 2024, representing an increase of 322.1%.</li><li>Net Loss: $42,290,005 for the nine months ended September 30, 2025, compared to $2,451,987 for the same period in 2024, representing an increase of 1624.7%.</li></ul><h3>Cash Flow</h3><ul><li>Net Cash Used in Operating Activities: - $1,148,534 for the nine months ended September 30, 2025, compared to - $809,302 for the same period in 2024.</li><li>Net Cash Provided by Financing Activities: $1,146,637 for the nine months ended September 30, 2025, compared to $717,503 for the same period in 2024.</li></ul><h3>Unique Metrics</h3><ul><li>Loss on Settlement of Debt: $35,458,137 for the nine months ended September 30, 2025, primarily due to the conversion of loans from the CEO and principal shareholder into shares of common stock.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Core Business Focus: The company plans to continue focusing on its core business areas, including the development and marketing of health and wellness products, as well as digital marketing services. The company aims to improve its financial performance by optimizing its marketing strategies and reducing operational costs.</li><li>Non-Core Business: The company has terminated certain license agreements and restructured its product offerings to focus on its most profitable products, such as NZT-48. The company has also entered into agreements to waive certain royalty payments, which will help reduce its financial liabilities.</li><li>Priority: The company emphasizes the importance of raising additional capital to fund its future operations and support its existing and planned business model. The company has not experienced difficulty in raising funds through loans and plans to continue seeking additional debt financing to support its operations.</li></ul>

Limitless X Holdings Inc. | 10-Q: FY2025 Q3 Revenue: USD 247.87 K